P E Belchetz

3.2k total citations · 1 hit paper
55 papers, 2.4k citations indexed

About

P E Belchetz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, P E Belchetz has authored 55 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in P E Belchetz's work include Pituitary Gland Disorders and Treatments (21 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Adrenal Hormones and Disorders (10 papers). P E Belchetz is often cited by papers focused on Pituitary Gland Disorders and Treatments (21 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Adrenal Hormones and Disorders (10 papers). P E Belchetz collaborates with scholars based in United Kingdom, United States and Belgium. P E Belchetz's co-authors include Richard McNally, Stephen M. Orme, Ray A. Cartwright, Alastair J.J. Wood, Julian H. Barth, Adam Balen, SM Orme, Chandrika Wijeyaratne, R.A. Cartwright and Steve Orme and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Brain Research.

In The Last Decade

P E Belchetz

54 papers receiving 2.2k citations

Hit Papers

Mortality and Cancer Inci... 1998 2026 2007 2016 1998 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
P E Belchetz 1.7k 394 362 327 279 55 2.4k
C G Beardwell 1.9k 1.1× 446 1.1× 599 1.7× 286 0.9× 406 1.5× 77 3.6k
S Shalet 1.5k 0.9× 525 1.3× 389 1.1× 338 1.0× 539 1.9× 53 2.9k
F. De Luca 924 0.6× 327 0.8× 328 0.9× 382 1.2× 463 1.7× 76 2.0k
Nancy J. Hopwood 1.1k 0.7× 296 0.8× 387 1.1× 265 0.8× 535 1.9× 45 1.7k
G Pieters 1.3k 0.8× 164 0.4× 420 1.2× 213 0.7× 183 0.7× 80 1.9k
John C. Stevenson 586 0.4× 202 0.5× 299 0.8× 531 1.6× 434 1.6× 44 2.3k
Gordana M. Prelević 758 0.5× 604 1.5× 102 0.3× 462 1.4× 259 0.9× 82 1.8k
Zehra Aycan 886 0.5× 205 0.5× 312 0.9× 559 1.7× 687 2.5× 220 2.2k
Kathleen Laborde 868 0.5× 151 0.4× 416 1.1× 186 0.6× 590 2.1× 55 1.8k
Dorothy I. Shulman 1.0k 0.6× 188 0.5× 358 1.0× 602 1.8× 472 1.7× 69 1.9k

Countries citing papers authored by P E Belchetz

Since Specialization
Citations

This map shows the geographic impact of P E Belchetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P E Belchetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P E Belchetz more than expected).

Fields of papers citing papers by P E Belchetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P E Belchetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P E Belchetz. The network helps show where P E Belchetz may publish in the future.

Co-authorship network of co-authors of P E Belchetz

This figure shows the co-authorship network connecting the top 25 collaborators of P E Belchetz. A scholar is included among the top collaborators of P E Belchetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P E Belchetz. P E Belchetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijeyaratne, Chandrika N., Krishnarajah Nirantharakumar, Adam Balen, et al.. (2004). Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?. Clinical Endocrinology. 60(5). 560–567. 64 indexed citations
2.
Ray, Sanghamitra & P E Belchetz. (2002). Xanthoma Disseminatum: A rare cause of hypopituitarism. 3. 1 indexed citations
3.
Wijeyaratne, Chandrika, Adam Balen, Julian H. Barth, & P E Belchetz. (2002). Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clinical Endocrinology. 57(3). 343–350. 234 indexed citations
4.
Orme, Stephen M., Richard McNally, Ray A. Cartwright, & P E Belchetz. (1998). Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1. The Journal of Clinical Endocrinology & Metabolism. 83(8). 2730–2734. 671 indexed citations breakdown →
5.
Orme, Steve, et al.. (1998). Bilateral sequential inferior petrosal sinus sampling with corticotrophin-releasing hormone stimulation in the diagnosis of Cushing's disease. European Journal of Endocrinology. 139(2). 161–166. 9 indexed citations
7.
Barth, Julian H., Melvin E. Jenkins, & P E Belchetz. (1997). Ovarian hyperthecosis, diabetes and hirsuties in post‐menopausal women. Clinical Endocrinology. 46(2). 123–128. 48 indexed citations
8.
Orme, SM, et al.. (1997). The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clinical Endocrinology. 46(4). 445–450. 45 indexed citations
9.
Orme, SM, et al.. (1997). Cognitive dysfunction in patients treated for pituitary tumours. Journal of Clinical and Experimental Neuropsychology. 19(1). 1–6. 60 indexed citations
10.
Padayatty, Sebastian J., et al.. (1996). Octreotide treatment increases exercise capacity in patients with acromegaly. European Journal of Endocrinology. 134(5). 554–559. 24 indexed citations
11.
Nagi, Dinesh, William G. Jones, & P E Belchetz. (1994). Gynaecomastia caused by a primary mediastinal seminoma. Clinical Endocrinology. 40(4). 545–548. 12 indexed citations
12.
Orme, Steve, Maggie Simpson, S.P. Stewart, et al.. (1994). Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation. Clinical Endocrinology. 41(2). 245–250. 16 indexed citations
13.
Orme, Steve, B. Oldroyd, S.P. Stewart, et al.. (1992). Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clinical Endocrinology. 37(5). 453–459. 53 indexed citations
14.
Harvey, Jeremy N., Carl Gray, & P E Belchetz. (1992). Oncogenous osteomalacia and malignancy. Clinical Endocrinology. 37(4). 379–384. 36 indexed citations
15.
Harvey, Jeremy N., et al.. (1991). Disturbance of osmoregulated thirst and vasopressin secretion in thyrotoxicosis. Clinical Endocrinology. 35(1). 29–33. 4 indexed citations
16.
Belchetz, P E. (1989). Hormone replacement treatment.. BMJ. 298(6686). 1467–1468. 23 indexed citations
17.
Crawford, Pamela, P E Belchetz, Catherine M. Davis, & D Chadwick. (1989). Growth hormone response to diazepam, clonidine and glucagon in patients with epilepsy. Epilepsy Research. 3(1). 63–69. 4 indexed citations
18.
Casson, I. F., John C. Davis, R. V. Jeffreys, et al.. (1987). SUCCESSFUL MANAGEMENT OF CUSHING'S DISEASE DURING PREGNANCY BY TRANSSPHENOIDAL ADENECTOMY. Clinical Endocrinology. 27(4). 423–428. 38 indexed citations
19.
Belchetz, P E. (1985). Idiopathic hypopituitarism in the elderly.. BMJ. 291(6490). 247–248. 13 indexed citations
20.
Casson, I. F., et al.. (1985). Intolerance of bromocriptine: is metergoline a satisfactory alternative?. BMJ. 290(6484). 1783–1784. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026